| Tumor necrosis factor α stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL–RANK interaction K Kobayashi, N Takahashi, E Jimi, N Udagawa, M Takami, S Kotake, ... The Journal of experimental medicine 191 (2), 275-286, 2000 | 1645 | 2000 |
| Osteoclast differentiation independent of the TRANCE–RANK–TRAF6 axis N Kim, Y Kadono, M Takami, J Lee, SH Lee, F Okada, JH Kim, ... The Journal of experimental medicine 202 (5), 589-595, 2005 | 452 | 2005 |
| A novel member of the leukocyte receptor complex regulates osteoclast differentiation N Kim, M Takami, J Rho, R Josien, Y Choi The Journal of experimental medicine 195 (2), 201-209, 2002 | 349 | 2002 |
| Interferon regulatory factor-8 regulates bone metabolism by suppressing osteoclastogenesis B Zhao, M Takami, A Yamada, X Wang, T Koga, X Hu, T Tamura, K Ozato, ... Nature medicine 15 (9), 1066-1071, 2009 | 333 | 2009 |
| Stimulation by toll-like receptors inhibits osteoclast differentiation M Takami, N Kim, J Rho, Y Choi The Journal of Immunology 169 (3), 1516-1523, 2002 | 290 | 2002 |
| Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from … K Itoh, N Udagawa, K Kobayashi, K Suda, X Li, M Takami, N Okahashi, ... The Journal of Immunology 170 (7), 3688-3695, 2003 | 237 | 2003 |
| Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation K Suda, N Udagawa, N Sato, M Takami, K Itoh, JT Woo, N Takahashi, ... The Journal of Immunology 172 (4), 2504-2510, 2004 | 219 | 2004 |
| Osteoimmunology: interactions of the immune and skeletal systems J Rho, M Takami, Y Choi Molecules and cells 17 (1), 1-9, 2004 | 189 | 2004 |
| Cells of bone: osteoclast generation N Takahashi, N Udagawa, M Takami, T Suda Principles of bone biology, 109-126, 2002 | 155* | 2002 |
| The identification of an osteoclastogenesis inhibitor through the inhibition of glyoxalase I M Kawatani, H Okumura, K Honda, N Kanoh, M Muroi, N Dohmae, ... Proceedings of the National Academy of Sciences 105 (33), 11691-11696, 2008 | 151 | 2008 |
| Lipopolysaccharide supports survival and fusion of preosteoclasts independent of TNF‐α, IL‐1, and RANKL K Suda, JT Woo, M Takami, PM Sexton, K Nagai Journal of cellular physiology 190 (1), 101-108, 2002 | 150 | 2002 |
| Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-β1 K Tachi, M Takami, H Sato, A Mochizuki, B Zhao, Y Miyamoto, ... Tissue engineering Part A 17 (5-6), 597-606, 2011 | 144 | 2011 |
| Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity A Irie, M Takami, H Kubo, N Sekino-Suzuki, K Kasahara, Y Sanai Bone 41 (2), 165-174, 2007 | 135 | 2007 |
| Intracellular calcium and protein kinase C mediate expression of receptor activator of nuclear factor-κB ligand and osteoprotegerin in osteoblasts M Takami, N Takahashi, N Udagawa, C Miyaura, K Suda, JT Woo, ... Endocrinology 141 (12), 4711-4719, 2000 | 127 | 2000 |
| Interleukin-1β induces death in chondrocyte-like ATDC5 cells through mitochondrial dysfunction and energy depletion in a reactive nitrogen and oxygen species-dependent manner R Yasuhara, Y Miyamoto, T Akaike, T Akuta, M Nakamura, M Takami, ... Biochemical Journal 389 (2), 315-323, 2005 | 123 | 2005 |
| Shared and distinct functions of the transcription factors IRF4 and IRF8 in myeloid cell development M Yamamoto, T Kato, C Hotta, A Nishiyama, D Kurotaki, M Yoshinari, ... PloS one 6 (10), e25812, 2011 | 120 | 2011 |
| Importance of membrane‐or matrix‐associated forms of M‐CSF and RANKL/ODF in osteoclastogenesis supported by SaOS‐4/3 cells expressing recombinant PTH/PTHrP receptors K Itoh, N Udagawa, K Matsuzaki, M Takami, H Amano, T Shinki, Y Ueno, ... Journal of Bone and Mineral Research 15 (9), 1766-1775, 2000 | 117 | 2000 |
| Regulation of osteoclast differentiation and function by receptor activator of NFkB ligand and osteoprotegerin A Shiotani, M Takami, K Itoh, Y Shibasaki, T Sasaki The Anatomical Record: An Official Publication of the American Association …, 2002 | 115 | 2002 |
| Interleukin‐4 inhibition of osteoclast differentiation is stronger than that of interleukin‐13 and they are equivalent for induction of osteoprotegerin production from osteoblasts A Yamada, M Takami, T Kawawa, R Yasuhara, B Zhao, A Mochizuki, ... Immunology 120 (4), 573-579, 2007 | 111 | 2007 |
| Disabling of receptor activator of nuclear factor-κB (RANK) receptor complex by novel osteoprotegerin-like peptidomimetics restores bone loss in vivo X Cheng, M Kinosaki, M Takami, Y Choi, H Zhang, R Murali Journal of Biological Chemistry 279 (9), 8269-8277, 2004 | 101 | 2004 |
